Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Epcoritamab, CD20xCD3 DLBCL

Carolina Moreno

MD

🏢Hospital de la Santa Creu i Sant Pau🌐Spain

Medical Oncologist

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Carolina Moreno is a hematologist specializing in B-cell lymphomas who has contributed to the development and clinical evaluation of epcoritamab, a subcutaneously administered CD20xCD3 bispecific antibody. She participated in EPCORE NHL-1, the pivotal trial establishing epcoritamab in relapsed/refractory DLBCL. Her research addresses optimal step-up dosing strategies, CRS prevention, and combination approaches for bispecific antibodies in lymphoma. She contributes to European hematology guidelines on novel immunotherapy for aggressive lymphomas.

Share:

🧪Research Fields 研究领域

epcoritamab lymphoma
EPCORE trial
DLBCL bispecific antibody
subcutaneous bispecific
diffuse large B-cell lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Carolina Moreno 的研究动态

Follow Carolina Moreno's research updates

留下邮箱,当我们发布与 Carolina Moreno(Hospital de la Santa Creu i Sant Pau)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment